Burning Rock Biotech Limited (BNR)
USD 2.95
(0.34%)
USD 2.95
(0.34%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 3.69 Million CNY | -72.77% |
| 2022 | 13.55 Million CNY | -72.52% |
| 2021 | 49.31 Million CNY | 18439.85% |
| 2020 | 266 Thousand CNY | -98.85% |
| 2019 | 23.08 Million CNY | -75.27% |
| 2018 | 93.33 Million CNY | -39.31% |
| 2017 | 153.79 Million CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 80.98 Million CNY | 0.0% |
| 2024 Q1 | 7.97 Million CNY | 0.0% |
| 2023 Q2 | 7.12 Million CNY | -22.05% |
| 2023 FY | 3.69 Million CNY | -72.77% |
| 2023 Q4 | 3.69 Million CNY | -27.79% |
| 2023 Q3 | 5.11 Million CNY | -28.31% |
| 2023 Q1 | 9.14 Million CNY | -32.52% |
| 2022 Q4 | 13.55 Million CNY | -40.73% |
| 2022 Q3 | 22.86 Million CNY | -29.32% |
| 2022 Q2 | 32.34 Million CNY | -18.74% |
| 2022 FY | 13.55 Million CNY | -72.52% |
| 2022 Q1 | 39.81 Million CNY | -19.27% |
| 2021 Q2 | 63.13 Million CNY | -14.03% |
| 2021 Q4 | 49.31 Million CNY | -14.28% |
| 2021 FY | 49.31 Million CNY | 18439.85% |
| 2021 Q3 | 57.53 Million CNY | -8.87% |
| 2021 Q1 | 73.43 Million CNY | 27507.14% |
| 2020 Q1 | 36.76 Million CNY | 59.26% |
| 2020 Q4 | 266 Thousand CNY | -66.2% |
| 2020 Q3 | 787 Thousand CNY | -97.71% |
| 2020 FY | 266 Thousand CNY | -98.85% |
| 2020 Q2 | 34.34 Million CNY | -6.57% |
| 2019 Q1 | - CNY | -100.0% |
| 2019 Q3 | 11.34 Million CNY | 0.0% |
| 2019 FY | 23.08 Million CNY | -75.27% |
| 2019 Q4 | 23.08 Million CNY | 103.4% |
| 2018 Q4 | 93.33 Million CNY | 0.0% |
| 2018 FY | 93.33 Million CNY | -39.31% |
| 2017 FY | 153.79 Million CNY | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Aclaris Therapeutics, Inc. | 3.07 Million USD | -20.039% |
| Applied DNA Sciences, Inc. | 739.16 Thousand USD | -399.214% |
| Aspira Women's Health Inc. | 1.43 Million USD | -158.042% |
| Biodesix, Inc. | 35.22 Million USD | 89.524% |
| BioNexus Gene Lab Corp. | 98.76 Thousand USD | -3636.217% |
| bioAffinity Technologies, Inc. | 1.11 Million USD | -229.916% |
| bioAffinity Technologies, Inc. | 1.11 Million USD | -229.916% |
| Bionano Genomics, Inc. | 7.17 Million USD | 48.571% |
| CareDx, Inc | 28.27 Million USD | 86.951% |
| Check-Cap Ltd. | - USD | -Infinity% |
| Castle Biosciences, Inc. | 14.19 Million USD | 74.01% |
| DarioHealth Corp. | 24.59 Million USD | 84.995% |
| Exact Sciences Corporation | 2.47 Billion USD | 99.851% |
| Fulgent Genetics, Inc. | 10.11 Million USD | 63.505% |
| Guardant Health, Inc. | 1.13 Billion USD | 99.676% |
| ICON Public Limited Company | 3.66 Billion USD | 99.899% |
| IDEXX Laboratories, Inc. | 622.88 Million USD | 99.408% |
| Illumina, Inc. | 1.48 Billion USD | 99.752% |
| Intelligent Bio Solutions Inc. | 81.32 Thousand USD | -4437.406% |
| iSpecimen Inc. | 29.13 Thousand USD | -12567.353% |
| Standard BioTools Inc. | 3.98 Million USD | 7.356% |
| MDxHealth SA | 35.56 Million USD | 89.624% |
| 23andMe Holding Co. | 67.84 Million USD | 94.561% |
| Medpace Holdings, Inc. | 142.12 Million USD | 97.404% |
| Myriad Genetics, Inc. | 130.9 Million USD | 97.181% |
| Mainz Biomed B.V. | 2.19 Million USD | -68.041% |
| ENDRA Life Sciences Inc. | 192.06 Thousand USD | -1821.255% |
| NeoGenomics, Inc. | 606.06 Million USD | 99.391% |
| Neogen Corporation | 888.39 Million USD | 99.585% |
| Inotiv, Inc. | 399.4 Million USD | 99.076% |
| Natera, Inc. | 282.94 Million USD | 98.696% |
| OpGen, Inc. | 2.02 Million USD | -82.527% |
| OPKO Health, Inc. | 222.03 Million USD | 98.338% |
| Psychemedics Corporation | 945 Thousand USD | -290.476% |
| Prenetics Global Limited | 867.21 Thousand USD | -325.5% |
| Prenetics Global Limited | 867.21 Thousand USD | -325.5% |
| Precipio, Inc. | 106 Thousand USD | -3381.132% |
| Personalis, Inc. | 1.23 Million USD | -199.028% |
| RadNet, Inc. | 812.06 Million USD | 99.546% |
| Sera Prognostics, Inc. | 840 Thousand USD | -339.286% |
| Sotera Health Company | 2.22 Billion USD | 99.834% |
| Neuronetics, Inc. | 59.28 Million USD | 93.776% |
| Star Equity Holdings, Inc. | 1.14 Million USD | -222.271% |
| Star Equity Holdings, Inc. | 1.14 Million USD | -222.271% |
| Trinity Biotech plc | 54.65 Million USD | 93.248% |
| T2 Biosystems, Inc. | 6.59 Million USD | 44.074% |
| Twist Bioscience Corporation | 79.17 Million USD | 95.339% |
| Exagen Inc. | 19.23 Million USD | 80.812% |